ELTROMBOPAG CHOLINE
| Brand name | ALVAIZ |
|---|---|
| Active ingredient | ELTROMBOPAG CHOLINE |
| Strength | EQ 9MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | November 2023 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11072586 | November 2038 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.